← Back to Search

Dietary Supplement

Ketogenic Therapy for Epilepsy

N/A
Recruiting
Led By Peggy R. Borum, Ph.D.
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand how best to treat children with seizures that don't respond to available therapies.

Who is the study for?
This trial is for children with seizures not well-managed by current treatments. Participants must be prescribed a ketogenic diet by their doctor, able to process high fat and low carbohydrate diets according to lab tests, and willing to follow the therapy regimen and maintain records.
What is being tested?
The study investigates how Ketogenic Therapy affects children with epilepsy. It aims to understand how this high-fat, low-carbohydrate diet works as a treatment and determine the most effective way of administering it.
What are the potential side effects?
Potential side effects of Ketogenic Therapy may include digestive issues like constipation or diarrhea, changes in blood lipid levels, possible nutrient deficiencies, weight changes, and sometimes lethargy or irritability during initial adjustment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reduced seizures
Secondary study objectives
Pharmaceutical Preparations

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ketogenic TherapyExperimental Treatment1 Intervention
Ketogenic Therapy will be administered.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,397 Previous Clinical Trials
766,660 Total Patients Enrolled
3 Trials studying Seizures
673 Patients Enrolled for Seizures
Peggy R. Borum, Ph.D.Principal InvestigatorUniversity of Florida

Media Library

Ketogenic Therapy (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT02216500 — N/A
Seizures Research Study Groups: Ketogenic Therapy
Seizures Clinical Trial 2023: Ketogenic Therapy Highlights & Side Effects. Trial Name: NCT02216500 — N/A
Ketogenic Therapy (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02216500 — N/A
~97 spots leftby Oct 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top